Alamar Biosciences, Inc. (California) (ALMR)
29.41
-2.35
(-7.40%)
USD |
NASDAQ |
Nov 13, 10:26
Alamar Biosciences Free Cash Flow (Quarterly) : -15.37M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -15.37M |
| June 30, 2026 | -15.07M |
| March 31, 2026 | -21.12M |
| Date | Value |
|---|---|
| September 30, 2025 | -15.47M |
| June 30, 2025 | -13.00M |
| March 31, 2025 | -14.05M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Personalis, Inc. | -30.14M |
| 10X Genomics, Inc. | 14.86M |
| Champions Oncology, Inc. | -0.547M |
| Medpace Holdings, Inc. | 196.44M |
| Avantor, Inc. | 156.20M |